• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估两项旨在改善药物预先授权流程的举措的实施结果(可接受性、采用情况和可行性)。

Evaluating implementation outcomes (acceptability, adoption, and feasibility) of two initiatives to improve the medication prior authorization process.

作者信息

Jones Laney K, Ladd Ilene G, Gregor Christina, Evans Michael A, Graham Jove, Gionfriddo Michael R

机构信息

Geisinger Health System, 100 N Academy Avenue, Danville, PA, 17822, USA.

出版信息

BMC Health Serv Res. 2021 Nov 20;21(1):1259. doi: 10.1186/s12913-021-07287-2.

DOI:10.1186/s12913-021-07287-2
PMID:34801025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8606066/
Abstract

BACKGROUND

Processes such as prior authorization (PA) for medications, implemented by health insurance companies to ensure that safe, appropriate, cost-effective, and evidence-based care is provided to all members, have created inefficiencies within healthcare systems. Thus, healthcare systems have implemented supplemental processes to reduce burden and ensure efficiency, timeliness, and appropriate care.

OBJECTIVE

Evaluate implementation outcomes of two initiatives related to PA for medications: a common record that records all PA-related information that was integrated into the health record and an auto-routing of specialty prescriptions to a hospital-owned specialty pharmacy.

METHODS

We conducted semi-structured interviews with medical staff to understand their experience, acceptability, adoption, and feasibility of these initiatives guided by Proctor's Framework for Implementation Outcomes. Transcripts were analyzed using consensus coding.

RESULTS

Eleven medical staff participated in semi-structured interviews. The two initiatives were analyzed together because the findings were similar across both for our outcomes of acceptability, adoption, and feasibility. Participants found the implemented initiatives to be acceptable and beneficial but felt there were still challenges with the new workflow. The initiatives were fully adopted by only one clinic site within the healthcare system, but limitations arose when adopting to another site. Individuals felt the initiatives were feasible and improved workflow, communication, and transparency. However, participants described future adaptations that would help improve this process including improved standardization, automation, and transparency.

CONCLUSION

The acceptability, adoption, and feasibility of two initiatives to improve the PA process within the one clinical site were well received but issues of generalizability limited the initiatives adoption system wide.

摘要

背景

医疗保险机构实施的诸如药物预先授权(PA)等流程,旨在确保为所有成员提供安全、适当、具有成本效益且基于证据的医疗服务,但这些流程在医疗系统中造成了效率低下的问题。因此,医疗系统已实施补充流程以减轻负担并确保效率、及时性和适当的医疗服务。

目的

评估与药物PA相关的两项举措的实施效果:一个记录所有与PA相关信息并整合到健康记录中的通用记录,以及将专科处方自动路由到医院所属专科药房。

方法

我们对医务人员进行了半结构化访谈,以了解他们在普罗克特实施效果框架指导下对这些举措的体验、可接受性、采用情况和可行性。使用共识编码对访谈记录进行分析。

结果

11名医务人员参与了半结构化访谈。由于在可接受性、采用情况和可行性方面的结果相似,因此对这两项举措进行了综合分析。参与者认为已实施的举措是可接受且有益的,但觉得新工作流程仍存在挑战。这些举措仅在医疗系统内的一个诊所完全采用,但在推广到另一个诊所时出现了局限性。个人认为这些举措是可行的,并且改善了工作流程、沟通和透明度。然而,参与者描述了未来有助于改进此过程的调整措施,包括改进标准化、自动化和透明度。

结论

在一个临床站点内改善PA流程的两项举措的可接受性、采用情况和可行性受到好评,但普遍性问题限制了这些举措在整个系统中的采用。

相似文献

1
Evaluating implementation outcomes (acceptability, adoption, and feasibility) of two initiatives to improve the medication prior authorization process.评估两项旨在改善药物预先授权流程的举措的实施结果(可接受性、采用情况和可行性)。
BMC Health Serv Res. 2021 Nov 20;21(1):1259. doi: 10.1186/s12913-021-07287-2.
2
Analyzing the costs of developing and operating an integrated health-system specialty pharmacy: The case of a centralized insurance navigation process for specialty clinic patients.分析开发和运营一体化医疗系统专科药房的成本:以专科诊所患者集中保险导航流程为例。
Am J Health Syst Pharm. 2021 May 24;78(11):982-988. doi: 10.1093/ajhp/zxab083.
3
Understanding the medication prior-authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system.理解药物预先授权流程:来自大型农村综合卫生服务系统的患者和临床工作人员的案例研究。
Am J Health Syst Pharm. 2019 Mar 19;76(7):453-459. doi: 10.1093/ajhp/zxy083.
4
Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system.在大型医疗保健系统中实施电子预先授权对电子健康记录系统中药物配给的影响。
J Am Med Inform Assoc. 2021 Sep 18;28(10):2233-2240. doi: 10.1093/jamia/ocab119.
5
Implementation and impact assessment of integrated electronic prior authorization in an academic health system.在学术医疗体系中实施并评估综合电子预授权的效果。
J Am Pharm Assoc (2003). 2020 Jul-Aug;60(4):e93-e99. doi: 10.1016/j.japh.2020.01.012. Epub 2020 Feb 24.
6
Interactive and Participatory Audit and Feedback (IPAF): theory-based development and multi-site implementation outcomes with specialty clinic staff.交互式参与式审核与反馈(IPAF):基于理论的发展及专科诊所工作人员的多地点实施成果
Implement Sci Commun. 2021 May 31;2(1):58. doi: 10.1186/s43058-021-00155-4.
7
A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary care.一项系统咨询的可行性、可接受性和有效性的随机匹配对研究:一种在初级保健中采用阿片类药物处方临床指南的新型实施策略。
Implement Sci. 2018 Jan 25;13(1):21. doi: 10.1186/s13012-018-0713-1.
8
Delivering an iterative Communication Partner Training programme to multidisciplinary healthcare professionals: A pilot implementation study and process evaluation.为多学科医疗保健专业人员提供迭代沟通伙伴培训计划:试点实施研究和过程评估。
Int J Lang Commun Disord. 2021 May;56(3):620-636. doi: 10.1111/1460-6984.12618. Epub 2021 Apr 5.
9
Medication prior authorization from the providers perspective: A prospective observational study.从提供者角度看药物预先授权:一项前瞻性观察研究。
Res Social Adm Pharm. 2019 Sep;15(9):1138-1144. doi: 10.1016/j.sapharm.2018.09.019. Epub 2018 Sep 26.
10
The Tennessee Medicaid medication therapy management program: early stage contextual factors and implementation outcomes.田纳西州医疗补助药物治疗管理项目:早期背景因素与实施成果
BMC Health Serv Res. 2021 Nov 2;21(1):1189. doi: 10.1186/s12913-021-07193-7.

引用本文的文献

1
Feasibility of the online educational tool about the ActiveHip + mHealth intervention in occupational therapy students.针对职业治疗专业学生的关于ActiveHip +移动健康干预的在线教育工具的可行性。
BMC Med Educ. 2025 Mar 20;25(1):412. doi: 10.1186/s12909-025-06963-9.
2
A use case of ChatGPT: summary of an expert panel discussion on electronic health records and implementation science.ChatGPT的一个应用案例:关于电子健康记录与实施科学的专家小组讨论总结
Front Digit Health. 2024 Oct 24;6:1426057. doi: 10.3389/fdgth.2024.1426057. eCollection 2024.
3
A conceptual framework on determinants of the integrated tuberculosis control model implementation in China.中国综合结核病防治模式实施的决定因素概念框架。
Front Med (Lausanne). 2024 Aug 21;11:1407131. doi: 10.3389/fmed.2024.1407131. eCollection 2024.
4
Implementation and dissemination of home- and community-based interventions for informal caregivers of people living with dementia: a systematic scoping review.实施和推广针对痴呆症患者非专业照护者的家庭和社区干预措施:系统范围综述。
Implement Sci. 2023 Nov 8;18(1):60. doi: 10.1186/s13012-023-01314-y.
5
REducing delay through edUcation on eXacerbations for people with chronic lung disease: Study protocol of a single-arm pre-post study.通过对慢性肺病患者加重期的教育来减少延误:一项单臂前后研究的研究方案。
J Adv Nurs. 2022 Aug;78(8):2656-2663. doi: 10.1111/jan.15311. Epub 2022 May 27.

本文引用的文献

1
Medications requiring prior authorization across health insurance plans.医疗保险计划中需要事先授权的药物。
Am J Health Syst Pharm. 2020 Apr 1;77(8):644-648. doi: 10.1093/ajhp/zxaa031.
2
AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection.AMCP 合作论坛:优化适当药物选择的预先授权。
J Manag Care Spec Pharm. 2020 Jan;26(1):55-62. doi: 10.18553/jmcp.2020.26.1.55.
3
Understanding the medication prior-authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system.理解药物预先授权流程:来自大型农村综合卫生服务系统的患者和临床工作人员的案例研究。
Am J Health Syst Pharm. 2019 Mar 19;76(7):453-459. doi: 10.1093/ajhp/zxy083.
4
Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review.审查预先授权程序、患者结局和药学干预的影响:单中心回顾。
J Am Acad Dermatol. 2019 Dec;81(6):1308-1318. doi: 10.1016/j.jaad.2019.05.024. Epub 2019 May 16.
5
RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review.RE-AIM规划与评估框架:历经20年回顾,适应新科学与实践
Front Public Health. 2019 Mar 29;7:64. doi: 10.3389/fpubh.2019.00064. eCollection 2019.
6
Prior Authorization and Utilization Management Concepts in Managed Care Pharmacy.管理式医疗药学中的事先授权和利用管理概念。
J Manag Care Spec Pharm. 2019 Jun;25(6):641-644. doi: 10.18553/jmcp.2019.19069. Epub 2019 Apr 12.
7
Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation rates.综合专业药房可提高 PCSK9 抑制剂的可及性和起始治疗率。
J Clin Lipidol. 2019 Mar-Apr;13(2):254-264. doi: 10.1016/j.jacl.2019.01.003. Epub 2019 Jan 14.
8
Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost.评估美国医疗补助计划中强化预先授权和管理计划对慢性丙型肝炎治疗依从性和成本的影响。
J Am Pharm Assoc (2003). 2018 Sep-Oct;58(5):485-491. doi: 10.1016/j.japh.2018.06.013. Epub 2018 Jul 19.
9
Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy.预先授权和自付费用与患者获得 PCSK9 抑制剂治疗的关联。
JAMA Cardiol. 2017 Nov 1;2(11):1217-1225. doi: 10.1001/jamacardio.2017.3451.
10
The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review.《医保目录限制对患者和支付方结果的影响:系统文献回顾》。
J Manag Care Spec Pharm. 2017 Aug;23(8):893-901. doi: 10.18553/jmcp.2017.23.8.893.